Similar articles

• The antagonism of the effects of L-3,4-dihydroxyphenylalanine of spinal reflexes by adrenergic blocking agents.

  Baker RG, Anderson EG. Baker RG, et al. J Pharmacol Exp Ther. 1970 May;173(1):224-31. J Pharmacol Exp Ther. 1970. PMID: 4392761 No abstract available.
• A reappraisal of the actions of noradrenaline and 5-hydroxytryptamine on cerebral cortical neurons.

  Frederickson RC, Jordan LM, Phillis JW. Frederickson RC, et al. Comp Gen Pharmacol. 1972 Dec;3(12):443-56. doi: 10.1016/0010-4035(72)90058-4. Comp Gen Pharmacol. 1972. PMID: 4146860 No abstract available.
• Steric aspects of adrenergic drugs. XI. Interactions of dibenamine and beta adrenergic blockers.

  Patil PN, Tye A, May C, Hetey S, Miyagi S. Patil PN, et al. J Pharmacol Exp Ther. 1968 Oct;163(2):309-19. J Pharmacol Exp Ther. 1968. PMID: 4386625 No abstract available.
• Effects of the adrenergic receptor blocking agents on the ganglionic transmission.

  Kayaalp SO, McIsaac RJ. Kayaalp SO, et al. Eur J Pharmacol. 1969 Sep;7(3):264-9. doi: 10.1016/0014-2999(69)90090-9. Eur J Pharmacol. 1969. PMID: 4390872 No abstract available.
• Studies of the chemical nature of the alpha-adrenergic receptor. IV. Labeling studies on nerve-free rabbit aortic strips.

  Yong MS, Marks GS. Yong MS, et al. Biochem Pharmacol. 1969 Jul;18(7):1619-26. doi: 10.1016/0006-2952(69)90149-x. Biochem Pharmacol. 1969. PMID: 5806104 No abstract available.